ERBB2 and breast carcinoma: CCA-1.1 also exhibits better anticancer activity than that of PGV-1 in several cancer cells, including luminal A MCF-7, HER2-positive HCC1954, triple-negative 4T1 breast cancer cells, K562 leukemic cells, Caco2, and WiDr colon cancer cells28.